Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.

Haematologica - 1 Aug 2016

Laurent Camille, Fabiani Bettina, Do Catherine, Tchernonog Emmanuelle, Cartron Guillaume, Gravelle Pauline, Amara Nadia, Malot Sandrine, Palisoc Maryknoll Mawanay, Copie-Bergman Christiane, Glehen Alexandra Traverse, Copin Marie-Christine, Brousset Pierre, Pittaluga Stefania, Jaffe Elaine S, Coppo Paul

Abstract excerpt

Plasmablastic lymphoma is a rare and aggressive diffuse large B-cell lymphoma commonly associated with Epstein-Barr virus co-infection that most often occurs in the context of human immunodeficiency virus infection. Therefore, its immune escape strategy may involve the upregulation of immune-checkpoint proteins allowing the tumor immune evasion. However, the expression of these molecules was poorly studied in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epstein-Barr Virus Infections

Share to Herpesvirus 4, Human

Share to Immunomodulation

Share to Immunophenotyping

Share to Kaplan-Meier Estimate

Share to Translocation, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 27175027
DOI: 10.3324/haematol.2016.141978
PMCID: PMC4967577

Genes

MYC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.PMID 27175027Read ↗

MicroRNAs sequencing unveils distinct molecular subgroups of plasmablastic lymphomaSemantic proximity Read ↗

The molecular pathogenesis of Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a scoping review.Semantic proximity Read ↗

Epstein-Barr Virus-Positive Natural Killer/T-Cell LymphomaSemantic proximity Read ↗

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphomaSemantic proximity Read ↗

Programmed Cell Death 1 and Programmed Cell Death Ligands in Extranodal Natural Killer/T Cell Lymphoma: Expression Pattern and Potential Prognostic RelevanceSemantic proximity Read ↗

Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Case-Illustrated Narrative ReviewSemantic proximity Read ↗

Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.Semantic proximity Read ↗

Epstein-Barr virus and immune status imprint the immunogenomics of non-Hodgkin lymphomas occurring in immune-suppressed environments.Semantic proximity Read ↗

Recent Findings in the Regulation of Programmed Death Ligand 1 ExpressionSemantic proximity Read ↗

Immune Checkpoint Inhibitors to Treat Malignant LymphomasSemantic proximity Read ↗

Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomasSemantic proximity Read ↗

Immune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.